Skyscape Web Viewer : EBMG : Cardiovascular Disease and Vascular Diseases : Main Index

View All
Insulin therapy
Insulin treatment
Insulin
Integrin α4beta7
Intellectual disability
Intellectually disabled
Intensive Care
Intensive glucose lowering
Intensive glycaemic control Glycaemic Control for Slowing the Progression of Microvascular Complications in Diabetes Mellitus Treatment and Follow-Up in Type 2 Diabetes - Related Resources Effect of the Treatment of Type 2 Diabetes Mellitus on the Development of Cognitive Impairment and Dementia Perioperative Glycaemic Control for Diabetic Patients Undergoing Surgery Type 1 Diabetes: Insulin Treatment - Related Resources
Intensive glycemic control
Intercostal Needle Aspiration Vs Tube Drainage for Spontaneous Pneumothorax Diagnosis of Rib Fracture and Intercostal Nerve Block
Intercostal block
Intercostal retraction
Intercostal space Venous Hum Physiological Sound of Ejection
Interferon Alfa-2a Interferon Alfa for Neovascular Age-Related Macular Degeneration Pegylated Interferon for Chronic Hepatitis C
Interferon alfa
Interferon-α
Interferon-beta Azathioprine, Interferon Beta-1a or Methotrexate for Chronic Inflammatory Demyelinating Polyradiculoneuropathy Chemical Pleurodesis for Malignant Pleural Effusions Immunomodulators and Immunosuppressants for Relapsing-Remitting Multiple Sclerosis (Rrms): a Network Meta-Analysis Azathioprine for Multiple Sclerosis Fingolimod for Relapsing-Remitting Multiple Sclerosis
Interferons Immunoglobulins, Vaccines or Interferon for Preventing Cytomegalovirus Disease in Solid Organ Transplant Recipients Multiple Sclerosis (Ms) - Related Resources Ribavirin Plus Interferon Versus Interferon for Chronic Hepatitis C Interferon Alfa for Neovascular Age-Related Macular Degeneration Pegylated Interferon for Chronic Hepatitis C
Intensive Care, Neonatal
Intensive case management
Intercostal anesthesia
Intercostal nerve block
Intercourse
Interferon α
Interferon-α
Interferon beta
Interferon Type I, Recombinant
Interferon
Interleukin-2 Immunotherapy for Advanced Renal Cancer Interleukin 2 Receptor Antagonists for Kidney Transplant Recipients